Changes in paediatric respiratory infections at a UK teaching hospital 2016–2021; impact of the SARS-CoV-2 pandemic - 05/01/22
, Nicholas Richens a, Emily Lees c, Jack Cregan b, Elizabeth Kalimeris a, Sarah Oakley a, Marcus Morgan a, Shelley Segal a, Moya Dawson a, A. Sarah Walker b, d, e, David W. Eyre a, d, e, f, g, Derrick W. Crook a, b, d, e, Sally Beer a, Alex Novak a, Nicole E. Stoesser a, b, d, e, 1, Philippa C. Matthews a, b, d, e, 1, ⁎
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | Paediatric respiratory virus seasonality in Oxfordshire was altered by the SARS-CoV-2 pandemic. |
• | Detection of all pathogens was suppressed during the first national lockdown. |
• | SARS-CoV-2 incidence reflects the national pandemic infection curves. |
• | Rhinovirus and adenovirus rates increased when schools reopened Sept-Dec 2020. |
• | An inter-seasonal rise in RSV was seen in July 2021, influenza remained supressed. |
Abstract |
Objective To describe the impact of the SARS-CoV-2 pandemic on the incidence of paediatric viral respiratory tract infection in Oxfordshire, UK.
Methods Data on paediatric Emergency Department (ED) attendances (0–15 years inclusive), respiratory virus testing, vital signs and mortality at Oxford University Hospitals were summarised using descriptive statistics.
Results Between 1-March-2016 and 30-July-2021, 155,056 ED attendances occurred and 7,195 respiratory virus PCRs were performed. Detection of all pathogens was suppressed during the first national lockdown. Rhinovirus and adenovirus rates increased when schools reopened September-December 2020, then fell, before rising in March-May 2021. The usual winter RSV peak did not occur in 2020/21, with an inter-seasonal rise (32/1,000 attendances in 0–3 yr olds) in July 2021. Influenza remained suppressed throughout. A higher paediatric early warning score (PEWS) was seen for attendees with adenovirus during the pandemic compared to pre-pandemic (p = 0.04, Mann-Witney U test), no other differences in PEWS were seen.
Conclusions SARS-CoV-2 caused major changes in the incidence of paediatric respiratory viral infection in Oxfordshire, with implications for clinical service demand, testing strategies, timing of palivizumab RSV prophylaxis, and highlighting the need to understand which public health interventions are most effective for preventing respiratory virus infections.
Le texte complet de cet article est disponible en PDF.Keywords : Respiratory virus, Respiratory tract infection, Paediatric, SARS-CoV-2, Respiratory syncytial virus, Influenza, Rhinovirus
Plan
Vol 84 - N° 1
P. 40-47 - janvier 2022 Retour au numéro
Article précédent
- Immunocompromised children and young people are at no increased risk of severe COVID-19
- H. Chappell, R. Patel, C. Driessens, A.W. Tarr, W.L. Irving, P.J. Tighe, H.J. Jackson, T. Harvey-Cowlishaw, L. Mills, M. Shaunak, D. Gbesemete, A. Leahy, J.S. Lucas, S.N. Faust, H. de Graaf
- A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries
- Maria Victoria Humbert, Precious Chinonyerem Opurum, Nathan J Brendish, Stephen Poole, Peijun He, Ioannis Katis, Jerry Quaye, Yaw Bediako, Patrick Jacques Duriez, Robert W Eason, Collin Sones, Osbourne Quaye, Gordon A Awandare, Myron Christodoulides, Tristan W Clark, Peter K Quashie, Christopher J McCormick
Bienvenue sur EM-consulte, la référence des professionnels de santé.